本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

燃石医学

9.02
+0.41014.76%
成交量:2.82万
成交额:25.23万
市值:9,711.58万
市盈率:-4.86
高:9.30
开:8.55
低:8.55
收:8.61
52周最高:11.12
52周最低:2.18
股本:1,076.66万
流通股本:483.30万
量比:0.95
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):-1.8560
每股收益(LYR):-4.6135
净资产收益率:-22.58%
总资产收益率:-7.58%
市净率:1.22
市盈率(LYR):-1.96

数据加载中...

2025/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/26

SEC问询函

Form CORRESP - Correspondence
2024/11/26

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/30

SEC问询函

Form CORRESP - Correspondence
2023/08/11

SEC问询函

Form CORRESP - Correspondence
2023/04/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/20

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence